Valley Brook Capital Group, Inc. Abbott Laboratories Transaction History

Valley Brook Capital Group, Inc.

$126 Million
Q1 2025

A detailed history of Valley Brook Capital Group, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Valley Brook Capital Group, Inc. holds 10,590 shares of ABT stock, worth $1.43 Million. This represents 1.11% of its overall portfolio holdings.

Number of Shares

10,590

Previous 10,696 0.99%

Holding current value

$1.43 Million

Previous $1.21 Million 16.13%

% of portfolio

1.11%

Previous 0.91%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$111.1 - $140.22 $11,776 - $14,863	-106 Reduced 0.99%	10,590 $1.4 Million
Q4 2024 Jan 29, 2025	SELL	$111.93 - $119.39 $20,259 - $21,609	-181 Reduced 1.66%	10,696 $1.21 Million
Q3 2024 Oct 31, 2024	BUY	$100.07 - $118.13 $12,708 - $15,002	127 Added 1.18%	10,877 $1.24 Million
Q2 2024 Jul 26, 2024	SELL	$100.73 - $112.44 $2,518 - $2,811	-25 Reduced 0.23%	10,750 $1.12 Million
Q1 2024 May 01, 2024	SELL	$109.52 - $120.96 $195,712 - $216,155	-1,787 Reduced 14.23%	10,775 $1.22 Million
Q4 2023 Feb 06, 2024	SELL	$90.19 - $110.4 $49,604 - $60,720	-550 Reduced 4.19%	12,562 $1.38 Million
Q3 2023 Nov 03, 2023	BUY	$95.53 - $114.62 $4,776 - $5,731	50 Added 0.38%	13,112 $1.27 Million
Q2 2023 Jul 31, 2023	BUY	$100.78 - $112.29 $10,078 - $11,229	100 Added 0.77%	13,062 $1.42 Million
Q1 2023 May 04, 2023	BUY	$96.86 - $114.01 $14,529 - $17,101	150 Added 1.17%	12,962 $1.31 Million
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $28,518 - $33,456	-300 Reduced 2.29%	12,812 $1.41 Million
Q2 2022 Aug 08, 2022	BUY	$102.07 - $123.37 $10,207 - $12,337	100 Added 0.77%	13,112 $1.42 Million
Q1 2022 May 02, 2022	BUY	$114.02 - $139.04 $59,860 - $72,996	525 Added 4.2%	13,012 $1.54 Million
Q3 2021 Oct 21, 2021	SELL	$116.66 - $129.06 $29,165 - $32,265	-250 Reduced 1.96%	12,487 $1.48 Million
Q2 2021 Jul 22, 2021	BUY	$105.79 - $124.53 $16,503 - $19,426	156 Added 1.24%	12,737 $1.48 Million
Q1 2021 May 06, 2021	BUY	$108.84 - $128.23 $42,882 - $50,522	394 Added 3.23%	12,581 $1.51 Million
Q4 2020 Mar 19, 2021	BUY	$105.0 - $114.42 $1.28 Million - $1.39 Million	12,187 New	12,187 $1.33 Million

Others Institutions Holding ABT

# of Institutions

3,533

Shares Held

1.38B

Call Options Held

9.75M

Put Options Held

8.87M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $237B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Valley Brook Capital Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Valley Brook Capital Group, Inc. with notifications on news.

Account

Valley Brook Capital Group, Inc. Abbott Laboratories Transaction History